Since CXCL16 was able to activate Akt via inverse signaling mechanisms in brain tumors [62], the PI3K-AKT signaling pathway might be involved in the regulation of VEGFC expression via CXCL16, and probably via CX3CL1, during cellular dormancy exit. The gene discussed is CX3CL1; the disease is brain neoplasm.